Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Oxigene
Company Monitoring Page for Oxigene
latest headlines for company on cafepharma
Oxigene Receives Fast Track Designation From U.S. FDA for CA4P
Yahoo
Wed, 03/30/16 - 10:15 am
Tags:
Oxigene
,
fast track
,
FDA
,
CA4P
,
ovarian cancer
,
platinum-resistant ovarian cancer
Oxigene's pancreatic cancer treatments granted orphan drug status in Europe
Marketwatch
Sat, 03/26/16 - 01:01 pm
Tags:
Oxigene
,
pancreatic cancer
,
orphan drugs
,
CA4P
Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data
TheStreet.com
Wed, 11/12/14 - 08:38 am
Tags:
Oxigene
,
ovarian cancer
,
fosbretabulin
,
Avastin
8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Tue, 04/8/14 - 09:46 am
Tags:
Zohydro
,
Zogenix
,
Zybrestat
,
Oxigene
,
Arikayce
,
Insmed
,
obeticholic acid
,
Intercept Pharmaceuticals
Oxigene shares surge after positive clinical trial
Marketwatch
Wed, 03/12/14 - 10:12 am
Tags:
Oxigene
,
ovarian cancer
,
Zybrestat
OXiGENE's Oncology Drugs Have Run Their Course
Seeking Alpha
Wed, 05/1/13 - 11:01 am
Tags:
Oxigene
,
oncology
Risk Vs. Reward: 2 Biotech Stocks I'm Considering In The Wake Of Recent Developments
Seeking Alpha
Sat, 11/24/12 - 11:36 am
Tags:
Oxigene
,
Astex
4 Pharmaceutical Companies Moving On News
Seeking Alpha
Mon, 08/6/12 - 11:13 am
Tags:
Oxigene
,
Biostar Pharmaceuticals
,
Pluristem Therapeutics
,
Cellceutix
BIO CEO Conference Live Blog
TheStreet.com
Mon, 02/13/12 - 10:30 am
Tags:
BIO CEO Conference
,
Celsion
,
Cyclacel
,
Navidea Biopharmaceuticals
,
Chelsea Therapeutics
,
Titan
,
Galena Biopharma
,
Oxigene
You Should Have Seen These Biotech Failures Coming
Motley Fool
Sat, 11/5/11 - 02:44 pm
Tags:
Oxigene
,
Rexahn
Oxigene Headed Back Down On Disappointing Zybrestat Results
Seeking Alpha
Fri, 11/4/11 - 09:20 am
Tags:
Zybrestat
,
Oxigene
,
non-small cell lung cancer
Why Speculators Are Buzzing About OxiGENE
Seeking Alpha
Mon, 10/31/11 - 11:30 am
Tags:
Oxigene
,
Zybrestat
OXiGENE and Neoprobe Reawaken Investor Interest in Biotechnology Industry
Yahoo/MarketWire
Fri, 10/21/11 - 06:37 pm
Tags:
Oxigene
,
Neoprobe
,
investment
,
biotech
ASCO studies shake up drug stocks
Marketwatch
Tue, 06/7/11 - 06:22 pm
Tags:
ASCO
,
drug stocks
,
Sunesis
,
Exelixis
,
Bayer
,
Oxigene
,
Regeneron
,
EntreMed
Oxigene soars on Nasdaq update
Marketwatch
Mon, 06/6/11 - 10:20 am
Tags:
Oxigene
,
NASDAQ
OXiGENE Reports Encouraging Data From Phase 2 Trial of ZYBRESTAT(TM) in Non-small Cell Lung Cancer
Yahoo/Globe NewsWire
Sun, 06/5/11 - 10:07 am
Tags:
Oxigene
,
Zybrestat
,
non-small cell lung cancer
ASCO: Cancer Stock Winners, Losers
TheStreet.com
Thu, 05/19/11 - 01:56 pm
Tags:
ASCO
,
Vical
,
Oxigene
,
Agenus
,
Ariad Pharmaceuticals
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
Tags:
ASCO
,
Medivation
,
Exelixis
,
Dendreon
,
Bristol-Myers Squibb
,
Roche
,
Curis
,
Celgene
,
Sanofi
,
Ariad Pharmaceuticals
,
Merck
,
Incyte
,
Novartis
,
YM BioSciences
,
Pfizer
,
Aveo Pharmaceutical
,
ONYX Pharmaceuticals
,
Amgen
,
Synta
,
Vical
,
Oxigene
,
Cell Therapeutics
,
Oncothyreon
ZYBRESTAT(TM) (CA4P) Improves Overall Survival in a Phase 2/3 Trial (FACT Study) of Patients With Anaplastic Thyroid Cancer (ATC)
Yahoo/Globe NewsWire
Sun, 09/12/10 - 11:22 am
Tags:
Zybrestat
,
Oxigene
,
thyroid cancer
OXiGENE Reports Encouraging Safety and Efficacy Data from Ongoing Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2010 ASCO Annual Meeting
Yahoo/Globe NewsWire
Sun, 06/6/10 - 10:53 am
Tags:
Oxigene
,
non-small cell lung cancer
,
Zybrestat
Pages
1
2
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.